S. Saha

发表

Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey

M. Hudson, A. Tan, E. Bocci, 2023, Rheumatology International.

COVAD survey 2 long-term outcomes: unmet need and protocol

M. Hudson, C. Caballero-Uribe, A. Tan, 2022, Rheumatology International.

Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys.

C. Caballero-Uribe, A. Tan, O. Distler, 2023, Rheumatology.

Mental healthcare for young and adolescent LGBTQ+ individuals in the Indian subcontinent

D. Danda, Latika Gupta, A. Goel, 2023, Frontiers in Psychology.

Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study

C. Caballero-Uribe, A. Tan, E. Bocci, 2023, Rheumatology International.

Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey

C. Caballero-Uribe, A. Makol, T. Velikova, 2024, Rheumatology Advances in Practice.

Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.

C. Caballero-Uribe, A. Makol, T. Velikova, 2024, International journal of rheumatic diseases.

COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus

W. Katchamart, S. Shaharir, M. Dey, 2023, Journal of clinical medicine.

Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey

O. Distler, A. Makol, T. Velikova, 2023, Rheumatology international.

COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group

C. Caballero-Uribe, T. Velikova, J. Knitza, 2023, Rheumatology international.

Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.

C. Caballero-Uribe, W. Katchamart, S. Shaharir, 2024, Rheumatology international.

Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges

A. Makol, T. Velikova, N. Ziadé, 2024, International journal of rheumatic diseases.

Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study

T. Velikova, Latika Gupta, B. Barman, 2023, Journal of diabetes investigation.

Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies

A. Makol, T. Velikova, E. Nikiphorou, 2024, Rheumatology international.